We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Whole Genome Sequencing Identifies New Autism Signature

By LabMedica International staff writers
Posted on 25 Oct 2017
Print article
Image: The HiSeq X Ten sequencing system (Photo courtesy of Illumina).
Image: The HiSeq X Ten sequencing system (Photo courtesy of Illumina).
Current genetic tests for autism scan broad portions of the genome for DNA insertions or deletions that have previously been linked to autism. Other tests look for changes in the DNA building blocks of certain genes, but these tests flag only about 10% to 30% of cases.

Autism has genetic roots, but most cases can not be explained by current genetic tests.An analysis of the complete genomes of 2,064 people reveals that multiple genetic variations could contribute to autism. The work suggests that scanning whole genomes may one day be useful for clinical diagnostics.

Scientists at the Howard Hughes Medical Institute (Seattle, WA, USA) and their colleagues sequenced the genomes of 516 autistic children with no family history of autism, and no genetic anomalies detected by current tests. The team also sequenced the genomes of the children's parents and an unaffected sibling equaling 2,064 people in total. They analyzed each family's data, looking for genetic variations that occurred only in children with autism. Genomes were sequenced at the New York Genome Center (NYGC) using 1 μg of DNA, an Illumina polymerase chain reaction (PCR)-free library protocol, and sequencing on the Illumina X Ten platform. The team used the Quick Change Lightning Multi Site-Directed Mutagenesis Kit.

The investigators identified genetic changes that disrupted gene function and led to altered protein production, and genetic deletions too small to see with current tests. They also found changes in areas of the genome that do not contain genes, but are responsible for turning genes on. They compared the number of variations in autistic children's genomes with that of their unaffected siblings and found that children with autism were significantly more likely to have three or more different kinds of genetic variations.

Evan E. Eichler, PhD, the lead author of the study, said, “In five to 10 years, whole genome sequencing could be the most informative tool for autism diagnosis. Children with autism were significantly more likely to have three or more different kinds of genetic variations and that suggests that a combination of sporadic genetic variations could contribute to autism.” The study was published on September 28, 2017, in the journal Cell.

Related Links:
Howard Hughes Medical Institute

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Sampler device could revolutionize sample collection for diagnostic tests (Photo courtesy of ReadyGo Diagnostics)

First of Its Kind Universal Tool to Revolutionize Sample Collection for Diagnostic Tests

The COVID pandemic has dramatically reshaped the perception of diagnostics. Post the pandemic, a groundbreaking device that combines sample collection and processing into a single, easy-to-use disposable... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.